Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.910
-0.045 (-4.72%)
Apr 29, 2026, 9:22 AM EDT - Market open
SNTI Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 28 | 27 | 16 | 29 | 62 | 291 | |
| Market Cap Growth | -66.56% | 69.76% | -45.22% | -52.46% | -78.72% | - | |
| Enterprise Value | 42 | 45 | 40 | 27 | -21 | - | |
| Last Close Price | 0.96 | 1.04 | 3.51 | 6.60 | 14.10 | 98.60 | |
| PS Ratio | 1352.38 | 1242.84 | - | 11.48 | 14.43 | 105.23 | |
| PB Ratio | 5.28 | 4.89 | 0.32 | 0.44 | 0.49 | 4.81 | |
| P/TBV Ratio | 5.32 | 4.89 | 0.63 | 0.44 | 0.49 | - | |
| EV/Sales Ratio | 1904.92 | 2031.25 | - | 10.40 | - | - | |
| Debt / Equity Ratio | 5.17 | 5.17 | 0.66 | 0.56 | 0.29 | 0.38 | |
| Net Debt / Equity Ratio | 2.17 | 2.17 | -0.30 | 0.03 | -0.49 | -0.57 | |
| Net Debt / EBITDA Ratio | -0.22 | -0.22 | 0.30 | -0.03 | 1.03 | 0.87 | |
| Net Debt / FCF Ratio | -0.28 | -0.28 | 0.36 | -0.03 | 0.82 | 0.86 | |
| Asset Turnover | 0 | 0 | - | 0.02 | 0.03 | 0.04 | |
| Quick Ratio | 1.31 | 1.31 | 3.84 | 4.24 | 5.56 | 3.97 | |
| Current Ratio | 1.67 | 1.67 | 4.49 | 5.62 | 5.68 | 4.14 | |
| Return on Equity (ROE) | -218.08% | -218.08% | -89.73% | -85.91% | -52.94% | -121.15% | |
| Return on Assets (ROA) | -48.89% | -48.89% | -31.22% | -26.83% | -27.97% | -34.86% | |
| Return on Capital Employed (ROCE) | -156.50% | -156.50% | -64.10% | -60.30% | -38.10% | -49.20% | |
| Earnings Yield | -206.50% | -224.70% | -327.76% | -241.69% | -94.13% | -19.04% | |
| FCF Yield | -146.68% | -159.60% | -257.19% | -219.16% | -123.34% | -13.83% | |
| Buyback Yield / Dilution | -389.20% | -389.20% | -3.58% | -69.93% | -796.58% | 78.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.